Aug 06 2015

25th Monte Jade Annual Conference- 25 Years: Celebrating the Past, Envisioning the Future

Published by admin under Annual Conference


  • Event Date: Saturday, September 19, 2015
  • Time: Afternoon Program 1:00pm-5:00pm; Dinner Banquet 6:00pm-10:00pm
  • Location: Hyatt Santa Clara, 5101 Great America Parkway, Santa Clara, CA 95054
  • Registration: Online registration is required. Afternoon program is free if pre-registered, $5 on-site.
  • Dinner cost: $120. Seating is limited.
  • Announcement of the “Shark Tank for Startup” final participants: September 9, 2015
  • Contact: or (408)428-0388 for more information and sponsorship.

  • Theme: 25 Years: Celebrating the Past, Envisioning the Future 
  • Afternoon Keynote:
    Dr. Maverick Shih (施宣輝), President, BYOC Business Group, Acer Inc.
    Topic: Internet of Being– Creating the Value for New Cloud Era
  • Evening Keynote:
    Dr. Tien Wu (吳田玉), COO of ASE / Board Member of Global Semiconductor Association
    Topic: The Changing Landscape of Semiconductor

  • Panel Speakers:
    Session (a) Appreciate Monte Jade’s Past and Lead to Create the Future
    Session Chair: Maggie Li (李喬琚), New Hope Chinese Cancer Foundation

    Moderator: Ed Yang (楊耀武), iD Ventures America
    -Chih-Kai (CK) Cheng (鄭志凱), Acorn Pacific Ventures
    -Lilly Chung (鍾靜嫻), Deloitte
    -Hsing Kung (龔行憲), Acorn Campus
    -Hu Limin (胡立民), Ellie Mae
    -Bob Lin (林富元), Healthlink
    -Cheng-Chung Shih (施振強), Vishay

    Session (b) Venture Capital– Past, Present and Future
    Session Chair: Eric Huang (黃梓洋), COINX Ventures

    Moderator: Eric Huang (黃梓洋), COINX Ventures
    -Peter Hsieh (謝忠高), Acorn Pacific Ventures
    -Matt Huang (黃耀明), Armorize Technologies
    -Andrew Tang (湯忠), Draper University
    -Roger Royse, Royse Law Firm, PC
    -Jackie Yang (楊榮恭), TransLink Capital

    Session (c) Startup Presentation: “Shark Tank”
    Session Chair: Alan Wu (吳其鈞), AMobile

    Moderator: Peter Hsieh (謝忠高), Acorn Pacific Ventures
    -Limin Hu (胡立民), Ellie Mae
    -Tony Huang (黃君耀), WI Harper Group
    -Eric Huang (黃梓洋), COINX Ventures
    -Larry Wang (王南雷), Taiwan Innovation and Entrepreneurship Center
    -Stewart Wu (吳文燦), Cortina Systems
    -Jackie Yang (楊榮恭), Translink Capital

  • Session (d) Life: “Work-Life Balance”
    Session Chair: David Jeng (鄭詠升), Wintec Industries

    Moderator: David Jeng (鄭詠升), Wintec Industries
    -Logan Allin, ONEHOPE Wine
    -Derek Biazo, Alexander’s Steakhouse Cupertino
    -Yung Chen (陳永光), Silicon Valley Stem Cell Treatment Center
    -Amy Hoopes, Wente Vineyards
    -Katie Hsieh (謝凱婷), How Living 


    All Speaker Bio: here


  • Master of Ceremony:
    -Afternoon MC: Anne Hu (胡秀瑛)
    -Evening MC: Lily Chou Loh (周濼)
  • Entertainment:
    -Opening Performer: San Jose Taiko
    -Performing MC: Rambo Shyy (史浩辰)
    -Performer: Anthony Neely (倪安東)
    -Live Band: Silicon Valley Band

  • Agenda:
  • Afternoon Program
    12:00 -1:00 PM Registration
    1:00 -1:10 PM Welcome Remarks
    1:10- 2:00 PM Keynote Speech by Dr. Maverick Shih (施宣輝)
    Topic: Internet of Being– Creating the Value for New Cloud Era

    2:00- 3:15 PM
    Session (a) “Appreciate Monte Jade’s Past and Create the Future”
    Session (b) “Venture Capital– Past, Present and Future”

    3:15- 3:40 PM Break

    3:40- 4:45 PM
    Session (c) Startup Presentation: “Shark Tank”
    Session (d) Life: “Work-Life Balance”

    4:45- 5:00 PM Afternoon event closing remark


    Evening Program
    5:00- 5:30 PM Cocktail Reception
    5:30- 6:00 PM Registration

    6:00- 6:45 PM Dinner
    6:45- 7:00 PM San Jose Taiko Opening Performance
    7:00- 7:05 PM Welcome Remark
    7:05- 7:15 PM Award Ceremony
    -Lifetime Award to Dr. Chuang Yii-Der (莊以德)
    -Lifetime Award to Dr. Stan Shih (施振榮)
    7:15- 8:00 PM VIP Announcement

    8:00- 8:45 PM Evening Keynote Speech by Dr. Tien Wu (吳田玉)
    Topic: The Changing Landscape of Semiconductor
    8:45- 9:15 PM Performance: Anthony Neely (倪安東)
    9:15- 9:45 PM Performance: Silicon Valley Band
    9:45- 9:55 PM Prize Raffle
    9:55- End ……. Live Band



    No responses yet

    Jun 28 2015

    Special Forum (Jun. 2015): Special IOT Topic

    Published by admin under Others


    • Organizers: Monte Jade, ITRI International
    • Event Date: Monday, June 22, 2015
    • Time: 6:30PM-9:00PM
    • Speakers:
      Ray Yang (楊瑞臨), Deputy Director of Electronics Division at IEK of ITRI
    • Location: ITRI International, 2870 Zanker Rd., Suite 140, San Jose, CA95134
    • Contact Info:
    • Register: Free with pre-registration by 5 pm June 19  

    We have Ray Yang, Deputy Director of Electronics Division at IEK of ITRI, to share about IoT (including, 5 Must-know for Semiconductor Industry in Internet of Things-Wearable, Smart Home, Enterprise, Infrastructure, China).


    Speaker Bio:

    Ray Yang

    楊瑞臨 (Ray Yang),現任工研院產業經濟與趨勢研究中心(IEK)電子組計畫副組長兼通訊研究部經理,專精於半導體以及通訊產業研究與市場預測分析,於IEK擔任計畫主持人之研究專案包括2020無線技術群組前瞻計畫、台灣半導體產業協會委託IC產業動態觀測計畫、下世代記憶體技術趨勢與全球競合分析研究、電子系統層級(ESL)技術在新世代系統晶片應用發展趨勢探索研究、智慧可攜產品在自主健康管理之行動應用研究、以及通訊產業商情與產業競爭力分析等,而所主持的3D IC異質晶片整合應用趨勢探索計畫更榮獲經濟部法人科專「產業知識服務領航獎」殊榮;於IEK任職期間,除撰述發表超過40份中英文研究報告及專書之外,經濟日報、工商時報、聯合報、聯合晚報、自由時報、中央通訊社、非凡新聞等媒體專訪不下百次,並於2012年獲頒台灣亞太產業分析專業協進會(APIAA)產業顧問認證。


    美西玉山協會於六月二十二日晚間七點,與工研院北美公司在其會議廳共同舉辦特別講座「Special IOT Topic」,邀請到台灣工研院產業經濟與趨勢研究中心(IEK)電子組計畫副組長楊瑞臨先生分享對於物聯網 (IOT)的趨勢與觀察。

    楊瑞臨先生談到,Gartner研究指出,預計在2020年,科技產品收入中,只有20%會給半導體或硬體產業。楊瑞臨先生呼籲半導體業者必須有危機意識,及早因應。楊瑞臨先生談到半導體業者必須知道的物聯網五件事,包括穿戴式裝置興起,業者應延伸觸手到OS平台;智慧居家之潛在競爭;滿足垂直市場的需求;網路基本設施升級帶來的商機;以及中國在物聯網上發展的野心。他指出如果打不過對方,合作是必然。他也提到IOT 在B2B應用已漸漸普及。各先進國家例如美國、歐盟、德國、韓國、新加坡皆欲藉物聯網重掌科技主導地位。現場約有六十位來賓,許多來自於半導體產業,向講者請益如何因應IOT潮流。最後,美西玉山秘書長王韶華代表玉山贈禮,感謝講員楊瑞臨先生。


    No responses yet

    Mar 01 2015

    Monte Jade Forum (Mar. 2015): Recent Development in Intellectual Property Law and Litigation

    Published by admin under Monthly Meeting

    • Event Date: Thursday, March 26, 2015
    • Time: 6:30PM-9:00PM
    • Location: ITRI Int’l, 2870 Zanker Rd., Suite #140, San Jose, CA 95134
    • Speakers:
      Chris Chou (周堅維), IP partner in K&L Gates’ San Francisco Office and former Director of Intellectual Property, Legal for Taiwan Semiconductor Manufacturing Company, Ltd
      Patrick Ellisen, Greenberg Traurig, LLP
    • Moderator: Emil Chang, Managing Attorney, Venture Pacific Law
    • Topics:
      “Powerful and effective IP management strategies in light of a changing legal landscape”;
      “The Patent Office as the Alpha and Omega of patent disputes”;
      “How to slaughter a patent troll; what is working now”
    • Registration: Please register in advance. Click here.
    • Member & Student $10, Non-Member$20, extra $5 for site registration
    • Contact Info:
    • Light refreshments and drink will be provided.


    Speaker Bio:

    Chris Chou

    Chris Chou is an IP partner in K&L Gates’ San Francisco office. He is the former Director of Intellectual Property, Legal for Taiwan Semiconductor Manufacturing Company, Ltd., where he had overall management of intellectual property matters including inter alia, patents and trade secrets. At K&L Gates he is involved in patent litigation, patent application preparation, portfolio management, prosecution, and infringement/validity analysis in the areas of electronics, microprocessor, computer software, computer system/architecture and semiconductor devices/fabrication technologies. He has managed patent dispute matters in Taiwan and the U.S., and negotiated various deals including joint development projects, patent and technology license agreements, and patent acquisition transactions.


    Patrick Ellisen

    Mr. Ellisen’s practice focuses on intellectual property and general commercial litigation, as well as intellectual property protection, counseling and enforcement. He has broad experience handling various types of intellectual property disputes, including patent infringement actions in the U.S. District Courts and before the U.S. International Trade Commission and has particular experience in insurance coverage of intellectual property disputes. Mr. Ellisen also has wide-ranging experience in copyright, trademark and trade secret matters. He regularly advises clients on intellectual property and technology strategies and general business matters and negotiates and litigates intellectual property license agreements. Mr. Ellisen is a frequent lecturer on intellectual property management and best practices. Mr. Ellisen concentrates on Patent infringement; Intellectual property protection, counseling and exploitation; Commercial litigation; Copyright, trademark and trade secret. Mr. Ellisen holds J.D., University of California, Hastings College of the Law, 1989 and B.A., with honors, Political Science, University of California at Berkeley, 1986.


    No responses yet

    Jan 19 2015

    Monte Jade Tien’s Forum (Feb. 2015): A Retrospective: Professional and Personal Advice — When Opportunity Knocks, You Gotta Answer

    Published by admin under Tien Forum


    Susan will share her experience in her career path. From her graduation as a foreign student with no supporting network, to her ascendency onto Corporate boards. As she plugged along, without prospects to rise above mid-management level, she was given an opportunity for an acting executive position. She jumped in with both feet and worked to secure the position. Susan will reflect on the lessons learned and talk about giving back as a volunteer mentor today.



    Speaker Bio:

    Susan S. Wang

    Susan S. Wang retired from Solectron Corporation in 2002 after 18 years, having served as Executive Vice President for Corporate Development, Chief Financial Officer, and Corporate Secretary. She oversaw Solectron’s initial public offering and subsequent growth from a $40 million organization to a global corporation with more than $12 billion in revenue. A CPA, she began her career with Price Waterhouse and earlier held financial and managerial positions with Xerox Corporation and Westvaco Corporation. She currently serves on the Board of Directors and is Audit Committee Chair for Cirrus Logic, Nektar Therapeutics and Premier, Inc. and serves on Cirrus Logic’s Compensation Committee. Previously, Susan served on the Board of Directors of Calpine, Corp., Avanex, Inc., Rae Systems, Inc., Altera Corp. and Suntech Power Holding, Inc.


    No responses yet

    Nov 30 2014

    Monte Jade Forum (Jan. 2015): Breakthrough Treatment Options for Diverse Types of Cancer Patients with Immune-oncology Approaches

    Published by admin under Monthly Meeting

    • Event Date: Thursday, January 8, 2015
    • Time: 6:30PM-9:00PM
    • Location: ITRI Int’l, 2870 Zanker Rd., Suite #140, San Jose, CA 95134
    • Moderator and Panelists:
      Roxanne Duan, Director, External Collaborations, MedImmune, LLC. (Moderator)
      Cheng Liu, CEO of Eureka Therapeutics, Inc.
      Sonny Hsiao, CEO of Adheren, Inc.
      John C. Lin, VP, Experimental Medicine & Cancer Immunotherapy, Pfizer, Inc.
    • Registration: Please register in advance. Click here.
    • Member & Student $10, Non-Member$20, extra $5 for site registration
    • Contact Info:
    • Light refreshments and drink will be provided. 


    This panel discussion will focus on the recent breakthrough treatment options, namely “immune-oncology” approaches, for a variety of cancer. The moderator will give a general introduction of the immmuno-oncology approaches and a few examples of amazingly cancer patient responses, as high as response rate in the 90% range, to immune-oncology therapies. A panel of internationally renowned researchers, clinicians and entrepreneurs will be available to discuss current clinical trials, potential issues, and investment opportunities in immune-oncology therapies for different cancer, as well as hosting a Question & Answer session at the end.


    Speakers and Moderator Bio:

    Roxanne Duan

    Dr. Roxanne Duan joined MedImmune in 2012 as Director of External Collaborations. She spearheads external collaborations with academia, government and non-profit organizations and champions the formation of the Brazilian Science without Borders postdoc program at MedI. Before joining MedImmune, Roxanne was Director of External Discovery at GSK China with the goal to bring in assets from academic laboratories. Prior to GSK China, she was VP for R&D at Adlyfe, Inc., working on diagnostic methods and therapeutics for Alzheimer’s disease. Before Adlyfe, Roxanne was VP of R&D at Functional Genetics, Inc. where she led team to the invention and development of broad-spectrum antiviral therapeutics against human targets. Prior to Functional Genetics, Roxanne was a Project Leader at Human Genome Sciences, Inc. She discovered protein drugs from gene sequences and led teams to develop them, resulting in the filing of three protein drug INDs. Roxanne has a Ph.D. degree in Pharmaceutical Chemistry from University of California, San Francisco, did postdoctoral fellowships in tumor suppressor genes at the NIH and in growth factor signalling at HHMI, had extensive experiences in protein and antibody drug discovery. She also took on roles in the Advisory Board of Women in Bio and the head of Chinese Biopharmaceutical Association. Roxanne holds more than 30 original publications, 82 published patents and 26 allowed patents.


    Cheng Liu

    Dr. Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health.. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.


    John C. Lin

    Dr. John C. Lin is currently Vice President, Experimental Medicine & Cancer Immunotherapy at Pfizer Inc. John has worked at a biotech startup Rinat since 2002, through its acquisition by Pfizer in 2006. Before that he was a postdoctoral fellow at Genentech Inc. from 1999-2001. He obtained a Ph.D. in Biological and Biomedical Sciences from Harvard Medical School in 1998, and his M.D. from the College of Medicine of National Taiwan University in 1992.


    John is dedicated to developing novel immunotherapeutic agents to address the key mechanisms of serious human diseases. He investigated beta amyloid peptide’s impact on the age-related macular degeneration and Alzheimer’s disease. He conceived of the original idea of passive immunotherapy targeting PCSK9 for LDL lowering in 2006. His team also unveiled the critical roles of the cytokine interleukin 7 in the pathogenesis of multiple sclerosis and type 1 diabetes.


    In 2013 his research responsibility has expanded into leading the overall strategy of cancer immunology in Pfizer, including checkpoint inhibitors, co-stimulators and CAR T cell therapy. For instance, he is responsible for establishing Pfizer’s collaboration with MD Anderson Cancer Center’s Immunotherapy Platform (Jan 2014), collaboration with Cellectis on CAR-T technology (Jun 2014) and collaboration with Kyowa H. Kirin on 4-1BB / CCR4 combination therapy in solid tumors (Sep 2014).


    Sonny Hsiao

    Dr. Sonny Hsiao is CEO of Adheren, Inc. He manages R&D projects in the development of immunotherapies based on cell-conjugated antibodies for cancer. He also leads the development of a novel technology platform that uses chemical methods to conjugate any therapeutic moiety onto solid surfaces such as silicon, glass or living cells. As a young PI, Sonny is currently managing a NCI-IMAT R33 grant and several collaborations with academic laboratories, including David Schaffer lab at UC Berkeley, Zev Gartner lab at UCSF, Stuart Martin lab at U of Maryland, and Monica Hinds lab at OHSU. Sonny obtained his Ph.D. degree in Chemistry and Chembio from UC Berkeley.


    No responses yet

    Page: 1 2 3 ... 19